Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program.
Saved in:
| Title: | Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program. |
|---|---|
| Authors: | Pulley JM; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, 2525 West End Avenue, Nashville, TN, 37203, USA., Jerome RN; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, 2525 West End Avenue, Nashville, TN, 37203, USA., Ogletree ML; Department of Pharmacology, Vanderbilt University School of Medicine, 2220 Pierce Avenue, Nashville, TN, 37232, USA.; Points & Assists, LLC, Bala Cynwyd, PA, USA., Bernard GR; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, 2525 West End Avenue, Nashville, TN, 37203, USA., Lavieri RR; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, 2525 West End Avenue, Nashville, TN, 37203, USA., Zaleski NM; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, 2525 West End Avenue, Nashville, TN, 37203, USA., Hong CC; Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University School of Medicine, 2220 Pierce Avenue, Nashville, TN, 37232, USA.; Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, 465 21st Avenue South, Nashville, TN, 37232, USA., Shirey-Rice JK; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, 2525 West End Avenue, Nashville, TN, 37203, USA., Arteaga CL; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 2220 Pierce Avenue, Nashville, TN, 37232, USA.; Department of Cancer Biology, Vanderbilt University Medical Center, 2220 Pierce Avenue, Nashville, TN, 37232, USA.; Department of Medicine, Vanderbilt University Medical Center, 1161 21st Avenue South, Nashville, TN, 37232, USA., Mayer IA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 2220 Pierce Avenue, Nashville, TN, 37232, USA., Holroyd KJ; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, 2525 West End Avenue, Nashville, TN, 37203, USA.; Center for Technology Transfer and Commercialization, Vanderbilt University, 1207 17th Avenue South, Nashville, TN, 37212, USA., Cook RS; Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, 465 21st Avenue South, Nashville, TN, 37232, USA. Rebecca.Cook@Vanderbilt.Edu.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 2220 Pierce Avenue, Nashville, TN, 37232, USA. Rebecca.Cook@Vanderbilt.Edu.; Department of Biomedical Engineering, Vanderbilt University, 2301 Vanderbilt Place, Nashville, TN, 37235, USA. Rebecca.Cook@Vanderbilt.Edu. |
| Source: | Targeted oncology [Target Oncol] 2018 Feb; Vol. 13 (1), pp. 61-68. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Review |
| Journal Info: | Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1776-260X |
|---|---|
| DOI: | 10.1007/s11523-017-0542-1 |
